Find the latest Vaxcyte, Inc. (PCVX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 28, 2025 · Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro …

4 days ago · Get a real-time Vaxcyte, Inc. (PCVX) stock price with an overview of financials, statistics, forecasts, charts and more.

4 days ago · The last time I spoke about Vaxcyte, Inc. (NASDAQ:PCVX) it was in a Seeking Alpha article entitled "Vaxcyte: End Of Phase 2 Meeting FDA Q4 Of 2023 To Get Ball Rolling." With respect to this ...

A high-level overview of Vaxcyte, Inc. (PCVX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

4 days ago · Despite reporting positive results Monday from its mid-stage dose-finding study of VAX-24, its 24-strain pneumococcal vaccine, in healthy infants, Vaxcyte (NASDAQ:PCVX) has plummeted 56%.

Mar 26, 2025 · See the latest Vaxcyte Inc Ordinary Shares stock price (PCVX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Jan 15, 2025 · Live Update At 14:31:59 EST: On Wednesday, January 15, 2025 Vaxcyte Inc. stock [NASDAQ: PCVX] is trending up by 12.56%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Get the latest Vaxcyte Inc (PCVX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

5 days ago · In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Vaxcyte (PCVX – Research Report). The company’s shares closed last Friday at $69.46. The company’s ...